INTEGRATED ANNUAL REPORT 2026 AND NOTICE OF AGM 2026
READ OUR IAR AND NOTICE OF AGM Online meeting guide 2026
RESPONSIBLE BUSINESS REPORTS 2026
FINAL RESULTS 2026
Audited summary consolidated results for the year ended 30 June 2026 and cash dividend declarations
Results Presentation Webcast Playback READ OUR FINAL RESULTSRESTRUCTURING OF INTERESTS IN MEDICLINIC HOLDINGS IMPLEMENTATION OF TRANSACTION
Capitalised terms used in this announcement shall, unless otherwise defined herein or the context otherwise requires, have the same meanings as set out in Remgro's category 2 announcement dated 31 March 2026 ("Category 2 Announcement").
01 July 2026
Read AnnouncementINTERIM RESULTS 2025
Interim Report Unaudited Results for the six months ended 31 December 2025 and cash dividend declaration
Established in the 1940s by Dr Anton Rupert as a tobacco company, Remgro has evolved into a highly diversified investment holding company. Our interests fall mainly in the healthcare, consumer products, financial services, infrastructure and industrial sectors.
Remgro invests in reputable businesses that are aligned with its values and purpose, led by capable management teams with the potential to deliver superior earnings, sustainable cash flow generation and dividend growth over the long term. Remgro forges strategic alliances on a partnership basis and adds value through its extensive network of relationships.
at 30 June 2026
Headline earnings per share
R20.03
(up by 42.2%)
Adjusted free cash flow at the centre per share
R8.91
(up by 28.6%)
Ordinary dividend per share
595 cents
(up by 73.0%)
Special dividend per share
550 cents
Intrinsic net asset value per share
R305.80
(up by 4.6%)
As Remgro's portfolio evolves towards more unlisted exposure, our management philosophy has become more dynamic, adapting to the requirements of investee companies.
as at 30 June 2026
Remgro's healthcare portfolio comprises its restructured interests in Mediclinic, a leading international healthcare group with a more than four-decade heritage in Southern Africa. Following the implementation of the restructuring on 1 July 2026, Remgro owns 100% of Mediclinic Southern Africa and retains its 50% interest in Mediclinic Middle East, as well as its indirect interest in Spire Healthcare. Remgro no longer holds an interest in Hirslanden, Mediclinic's Swiss business. The investment continues to provide exposure to defensive, high-quality healthcare services, supported by strong operational performance, growing patient volumes and ongoing efficiency improvements. This sector contributes 23.6% of Remgro's net asset value.
DISCOVER SECTOR
Remgro’s consumer products portfolio comprises shareholdings in Heineken Beverages (18.8%), Siqalo Foods (100.0%), RCL Foods (79.4%), Rainbow (79.5%) and Capevin (33.6%) providing exposure to the food and beverage sector and supporting sustainable earnings growth and long-term value creation. This sector comprises 14.2% of Remgro’s net asset value.
Remgro's financial services portfolio includes shareholdings in OUTsurance (30.5%), Discovery (7.6%) and Business Partners (45.0%). These investments provide diversified exposure across the sector and underpin sustainable earnings growth and long-term value creation. This sector contributes 28.3% to Remgro's net asset value.
Remgro's industrial portfolio includes shareholdings in Air Products (50.0%), TotalEnergies (24.9%), and Wispeco (100%). These investments offer diversified exposure across the industrial sector and support sustainable earnings growth and long-term value creation. This sector contributes 7.4% to Remgro's net asset value.
Remgro's infrastructure portfolio comprises shareholdings in Community Investment Ventures Holdings (57.0%), Seacom (30.0%) and Ubiquity Energy (75.0%). These investments provide diversified sector exposure and support sustainable earnings growth and long-term value creation. This sector comprises 9.5% of Remgro's net asset value.
Remgro's diversified investment vehicles portfolio comprises shareholdings in KTH (43.5%), Prescient, Invenfin (100.0%), Asia Partners (6.5% Fund I, 10.0% Fund II) and Pembani Remgro Infrastructure Funds (14.9% Fund I, 24.6% Fund II). These investments offer diversified exposure across the diversified investment vehicles sector and support sustainable earnings growth and long-term value creation.
Remgro’s central treasury and net corporate assets pillars are inter alia responsible for Remgro’s central treasury function, management, support services as well as advancing community development and sporting excellence. This pillar includes wholly owned interests in Remgro Finance Corporation, Millennia Jersey, Remgro USA Jersey, Remgro Management Services (FSP 30 549), and V&R Management Services Switzerland, as well as Remgro’s impact investment shareholdings in the Blue Bulls (50.0%), Stellenbosch Academy of Sport (100%), Stellenbosch Football Club (100%) and the Boland Cavaliers (50.0%).
Access the latest information on Remgro and explore how we're delivering on our priorities.
2026 © Remgro Limited
Ethics hotline 0800 222 536
